Selective retina therapy (SRT) in patients with therapy refractory persistent acute central serous chorioretinopathy (CSC): 3 months functional and morphological results

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial

(2020) Andrew Lotery et al.   LANCET

Central serous chorioretinopathy: Towards an evidence-based treatment guideline

(2019) Thomas J. van Rijssen et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Clinical experience with eplerenone to treat chronic central serous chorioretinopathy

(2016) Bertan Cakir et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Selective Retina Therapy in Acute and Chronic-Recurrent Central Serous Chorioretinopathy

(2015) Carsten Framme et al.   OPHTHALMOLOGICA

Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis

(2015) Alejandra Daruich et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Selective retina therapy for acute central serous chorioretinopathy

(2010) C. Klatt et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Central serous chorioretinopathy

(2007) Maria Wang et al.   ACTA OPHTHALMOLOGICA